Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...

Roughly one in three preteens and teens ages 12 to 17 in the United States had prediabetes in 2023, according to new data ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

We're covering the myriad ways GLP-1 weight loss drugs are changing people's lives. (Photo illustration: Yahoo News; photos: ...

Weight-loss jabs such as Mounjaro could also help minimise asthma symptoms in obese people, says a new study, as the NHS ...

New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to ...

The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

Sulfonylureas as a whole are already known for their weight gain and hypoglycemia side effects. In practice, glipizide has ...